Literature DB >> 8626260

Cytotoxicity of hamycin for Trichomonas vaginalis, HeLa and BHK-21.

W B Lushbaugh1, J D Cleary, R W Finley.   

Abstract

Hamycin, a polyene antibiotic related to amphotericin B, has been used topically to treat fungal and protozoan infections in India. We assessed the cytotoxic activity of hamycin on nine metronidazole resistant or susceptible Trichomonas vaginalis strains isolated from symptomatic or asymptomatic patients. Cytotoxic activity of hamycin against two mammalian cell lines, BHK-21 and HeLa, was also determined. Tritiated thymidine pulse labeling after drug-washout and a recovery period was used to distinguish death of target cells from temporary static effects of the drug. Liposomal hamycin and hamycin formulated with dimethyl sulphoxide, deoxycholate or glycerin were compared. Although all hamycin preparations were trichomonacidal at approximately 1 mg/L, hamycin-dimethyl sulphoxide was stable for only 24 h, and hamycin glycerin was incompletely solubilized. Hamycin-deoxycholate remained a stable gel for 2 months at room temperature, but its activity was reduced four-fold when compared to the fresh preparation. The mammalian tissue culture cell lines HeLa and BHK-21 were killed by trichomonacidal concentrations of hamycin-deoxycholate. This cytotoxicity of hamycin for mammalian cells is a concern, but new forms of the drug are under development that may allow more widespread use of this drug.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8626260     DOI: 10.1093/jac/36.5.795

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Recalcitrant vaginal trichomoniasis.

Authors:  R S Pattman
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

Review 2.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis

Authors:  Zohreh Fakhrieh Kashan; Mahdi Delavari; Mohsen Arbabi; Hossein Hooshyar
Journal:  Iran Biomed J       Date:  2017-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.